Hepatitis C therapy before and after liver transplantation
- 29 September 2008
- journal article
- review article
- Published by Ovid Technologies (Wolters Kluwer Health) in Liver Transplantation
- Vol. 14 (S2), S58-S66
- https://doi.org/10.1002/lt.21624
Abstract
Liver Transpl 14:S58–S66, 2008. © 2008 AASLD.Keywords
This publication has 34 references indexed in Scilit:
- Clinical trial: peg-interferon alfa-2b and ribavirin for the treatment of genotype-1 hepatitis C recurrence after liver transplantationAlimentary Pharmacology & Therapeutics, 2008
- Safety, tolerability, and efficacy of pegylated‐interferon alfa‐2a plus ribavirin in HCV‐related decompensated cirrhoticsAlimentary Pharmacology & Therapeutics, 2008
- Efficacy of an escalating dose regimen of pegylated interferon ?-2a plus ribavirin in the early phase of HCV reinfection after liver transplantationTransplant International, 2007
- Sustained virologic response to therapy of recurrent hepatitis C after liver transplantation is related to early virologic response and dose adherenceLiver Transplantation, 2007
- Peginterferon alfa-2b and ribavirin in patients with hepatitis C virus and decompensated cirrhosis: A controlled studyJournal of Hepatology, 2007
- High incidence of allograft dysfunction in liver transplanted patients treated with pegylated-interferon alpha-2b and ribavirin for hepatitis C recurrence: possible de novo autoimmune hepatitis?Gut, 2007
- Combined treatment with pegylated interferon (α-2b) and ribavirin in the acute phase of hepatitis C virus recurrence after liver transplantationJournal of Hepatology, 2005
- Should we treat patients with chronic hepatitis C on the waiting list?Journal of Hepatology, 2005
- Applicability, Tolerability and Efficacy of Preemptive Antiviral Therapy in Hepatitis C-Infected Patients Undergoing Liver TransplantationAmerican Journal of Transplantation, 2005
- Treatment of HCV infection in patients with advanced cirrhosisHepatology, 2004